Shorts

1:00
Differentiating PNS From Treatment-Related Neurotoxicity
19 hours ago
by
Shailee Samir Shah, MD(+2 more)

1:01
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
2 days ago
by
Ditte Primdahl, MD(+2 more)

1:11
Differentiating Classic PNS from ICI-Related Toxicities
3 days ago
by
Ditte Primdahl, MD(+2 more)

0:27
Managing PNS in the Era of Immunotherapy
4 days ago
by
Shailee Samir Shah, MD(+2 more)

1:07
Prioritizing Malignancy Screening in Suspected PNS
6 days ago
by
Ditte Primdahl, MD(+2 more)

0:44
Screening Strategies for Suspected PNS
6 days ago
by
Shailee Samir Shah, MD(+2 more)

1:33
Phase 3b RESHAPE Trial Evaluates Switching From Ocrelizumab to Remibrutinib
7 days ago
by
Marisa McGinley, DO(+1 more)

0:50
Distinguishing PNS From Other Cancer-Associated Neurologic Complications
8 days ago
by
Ditte Primdahl, MD(+2 more)

1:19
Paraneoplastic Neurologic Syndromes at the Crossroads of Care
8 days ago
by
Shailee Samir Shah, MD(+2 more)

1:38
Interferon Signaling Pathways in the Brain Associated With MS Initiation
8 days ago
by
Louie Pasculli

1:33
Evolving Multiple Sclerosis Trials to Better Track Treatment Response
9 days ago
by
Daniel Ontaneda, MD, PhD(+1 more)

0:56
Growing Understanding of Duchenne Muscular Dystrophy Pathology
12 days ago
by
Jeffrey Chamberlain, PhD(+1 more)

0:56
2026 Parkinson Disease Therapeutic Outlook
14 days ago
by
Mariana Hernandez Gonzalez-Monje, MD, PhD(+1 more)

1:33
Analyzing Phase 3 OCEANIC-STROKE Data
15 days ago
by
Andrew Russman, DO(+1 more)

1:23
Exploring the Difference Between Pediatric and Adult MS Patients
15 days ago
by
Louie Pasculli

1:24
Therapies on the Horizon in Multiple Sclerosis
15 days ago
by
Katrina Bawden, MSN, MSCN, FNP-C(+1 more)

1:33
Using iPSC Models to Predict Multiple Sclerosis Therapeutic Response
16 days ago
by
Valentina Fossati, PhD(+1 more)

2:07
What’s Ahead for Movement Disorder Care in 2026
17 days ago
by
Kathrin LaFaver, MD, FAAN, DipABLM(+1 more)

1:33
Investigating the Mechanisms of PIRA Using In Vitro Models
18 days ago
by
Valentina Fossati, PhD(+1 more)

1:24
Understanding the Link Between EBV and MS
20 days ago
by
Micah Luftig(+1 more)

1:33
Unearthing Whether MS Onset Occurs Before EBV Infection
21 days ago
by
Dalia Rotstein, MD, MPH(+1 more)

1:33
ACTRIMS 2026: Clinical Perspectives
23 days ago
by
Daniel Ontaneda, MD, PhD(+1 more)

1:02
Exploring the Mechanisms of Bazedoxifene Acetate (BZA)
23 days ago
by
Riley Bove, MD(+1 more)

2:04
Building Pediatric Neurology Rapport Through Spanish
a month ago
by
Swathi Tata (+1 more)

1:22
Neurological Exam in Spanish for Culturally Competent Care
a month ago
by
Anne Francine Pino(+1 more)

2:08
Mentoring to Expand the Child Neurology Workforce
a month ago
by
Adam Wallace, MD(+1 more)

2:06
Building the Child Neurology Workforce Earlier in Training
a month ago
by
John Pugh, MD, PhD(+1 more)

1:29
Improving Equitable Care Access in Child Neurology
a month ago
by
Jordan Cole, MD(+1 more)

1:34
Responsible and Inclusive Clinical Research Practices
a month ago
by
Jennifer Yang, MD(+1 more)

1:30
Representation in Pediatric Neurology Research
a month ago
by
Senyene Hunter, MD, PhD(+1 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Breaking Down the 2026 Acute Ischemic Stroke Guidelines
2
Fenebrutinib Achieves Primary End Point in Phase 3 Head-to-Head Trial vs Teriflunomide in Relapsing MS
3
Real-World Effectiveness of Eptinezumab After CGRP Preventive Failure: Amaal Starling, MD, FAHS, FAAN
4
Real-World INFUSE Data Show IV Eptinezumab Improves Outcomes After CGRP Failure
5
